Temple University Hospital has become the first U.S. hospital to treat a patient with the Spiration® Valve System, a minimally invasive treatment for severe emphysema, following U.S. Food and Drug Administration (FDA) approval.
Welcome to high noon on Match Day 2019 – the exact hour and day when all fourth-year medical students across the country open a sealed envelope and learn where they “matched” for their residency.
A total of $700,000 awarded to researchers at Temple, Children’s Hospital of Philadelphia, University of Pennsylvania and University of Delaware to Accelerate Technology Commercialization
The NHA is comprised of a network of hospitals committed to advancing women’s heart health and seeks to ensure that women in all communities who are living with heart disease have access to information, education and patient support services.